178 related articles for article (PubMed ID: 24472072)
1. Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population.
Cao Y; Chen W; Qian Y; Zeng Y; Liu W
Int J Neurosci; 2014 Dec; 124(12):874-81. PubMed ID: 24472072
[TBL] [Abstract][Full Text] [Related]
2. ATP-binding cassette transporter A1 R219K polymorphism and ischemic stroke risk in the Chinese population: a meta-analysis.
Hou R; Zhu X; Pan X; Guo R; Ma T; Xu X
J Neurol Sci; 2014 Jan; 336(1-2):57-61. PubMed ID: 24157307
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
Li YY
PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
[TBL] [Abstract][Full Text] [Related]
4. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
Xu X; Li J; Sheng W; Liu L
Cerebrovasc Dis; 2008; 26(1):48-62. PubMed ID: 18511872
[TBL] [Abstract][Full Text] [Related]
6. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.
Chen CH; Eng HL; Chang CJ; Tsai TT; Lai ML; Chen HY; Liu CJ; Lin TM
J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956
[TBL] [Abstract][Full Text] [Related]
7. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.
Natesirinilkul R; Sasanakul W; Chuansumrit A; Kadegasem P; Visudtibhan A; Wongwerawattanakoon P; Sirachainan N
J Stroke Cerebrovasc Dis; 2014; 23(10):2566-2572. PubMed ID: 25284719
[TBL] [Abstract][Full Text] [Related]
8. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
[TBL] [Abstract][Full Text] [Related]
9. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
10. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
[TBL] [Abstract][Full Text] [Related]
13. The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.
Akhter MS; Biswas A; Abdullah SM; Behari M; Saxena R
Clin Appl Thromb Hemost; 2017 Nov; 23(8):1071-1076. PubMed ID: 28460568
[TBL] [Abstract][Full Text] [Related]
14. Association of PAI-1 4G/5G Polymorphism with Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus.
Li G; Liu Y; Li X; Ning Z; Sun Z; Zhang M; Lu Y; Wu L; Wang L
Genet Test Mol Biomarkers; 2018 Sep; 22(9):554-560. PubMed ID: 30160528
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T
PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
17. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
[TBL] [Abstract][Full Text] [Related]
18. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.
Wei Z; Chang K; Fan C
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365
[TBL] [Abstract][Full Text] [Related]
19. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
[TBL] [Abstract][Full Text] [Related]
20. [Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].
Guan L; Ji X; Wang J; Zhang A; Zhang Y; Zhao L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):393-6. PubMed ID: 12362314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
